Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Clinical and Intermediate Phenotypes to Assess Response to Quetiapine: the Role of Putative Causative Genes

NCT01044914 is registered in ClinicalTrials.gov with University of Bari as lead sponsor.

NCT NCT01044914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01044914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Clinical and Intermediate Phenotypes to Assess Response to Quetiapine: the Role of Putative Causative Genes
Lead sponsor
University of Bari
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
October 31, 2010
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia